Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-67571244 |
Trade Name | |
Synonyms | JNJ67571244|JNJ 67571244 |
Drug Descriptions |
JNJ-67571244 is a bispecific antibody that binds to CD33 and CD3, which potentially activates T-lymphocytes leading to increased cytotoxicity and reduced tumor growth of CD33-expressing cancer cells (PMID: 32150609). |
DrugClasses | CD3 Antibody 103 CD33 Antibody 15 |
CAS Registry Number | NA |
NCIT ID | C162296 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-67571244 | JNJ-67571244 | 0 | 1 |